Chao Zhou
Vermögen: 341 649 $ am 31.05.2026
Vermögen: 341 649 $ am 31.05.2026
Chao Zhou is Chief Executive Officer & Executive Director at Grand Pharmaceutical Group Ltd. since 2023.
Mr. Zhou is Director at Cloudbreak Therapeutics LLC since 2018.
Mr. Zhou is Director at Grand Pharma Sphere Pte Ltd. since 2018.
Former roles include Director at OncoSec Medical, Inc. from 2020 to 2023, Non-Executive Director at Cloudbreak Pharma, Inc. from 2021 to 2024, Business Director & Legal Manager at China Grand Enterprises, Inc. from 2013 to 2019, and Director at Sirtex Medical Pty Ltd. Education includes graduate degrees from the University of International Business & Economics in 2013 and Ocean University of China in 2011.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.04.2026 | 511 000 ( 0,01 % ) | 341 649 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GRAND PHARMACEUTICAL GROUP LIMITED | Vorstandsvorsitzender | 01.06.2021 |
Grand Pharma Sphere Pte Ltd.
Grand Pharma Sphere Pte Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | 01.01.2018 |
Cloudbreak Therapeutics LLC
Cloudbreak Therapeutics LLC BiotechnologyHealth Technology Operates as biotechnology company which engages in drug development | Direktor/Vorstandsmitglied | 01.01.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Direktor/Vorstandsmitglied | 14.06.2023 |
China Grand Enterprises, Inc.
China Grand Enterprises, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | General Counsel | 01.01.2019 |
| SIRTEX MEDICAL LIMITED | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
OncoSec Medical, Inc.
OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
Sirtex Medical Pty Ltd.
Sirtex Medical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of treatment for liver cancer | Commercial Services |
University of International Business & Economics
University of International Business & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Grand Enterprises, Inc.
China Grand Enterprises, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Grand Pharmaceutical Group Ltd.
Grand Pharmaceutical Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical and health products | Health Technology |
Ocean University of China
Ocean University of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cloudbreak Therapeutics LLC
Cloudbreak Therapeutics LLC BiotechnologyHealth Technology Operates as biotechnology company which engages in drug development | Health Technology |
Grand Pharma Sphere Pte Ltd.
Grand Pharma Sphere Pte Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen